Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β

Alzheimer’s disease (AD) is the most common form of dementia and may contribute to 60–70% of cases. Worldwide, around 50 million people suffer from dementia and the prediction is that the number will more than triple by 2050, as the population ages. Extracellular protein aggregation and plaque depos...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogt, Anne-Cathrine S., Jennings, Gary T., Mohsen, Mona O., Vogel, Monique, Bachmann, Martin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961492/
https://www.ncbi.nlm.nih.gov/pubmed/36835301
http://dx.doi.org/10.3390/ijms24043895

Ejemplares similares

Ejemplares similares